|
Canada-0-Engineering ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Nkarta Inc. | Natural Killer Cell Therapy Autoimmune Care
Learn about Nkarta, a clinical stage biotechnology company advancing the development of natural killer therapies to treat autoimmune disease
- Nkarta, Inc. (NKTX) Stock Price, News, Quote History - Yahoo Finance
Nkarta, Inc , a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment
- Nkarta lays off 3rd of staff to fund autoimmune CAR NK program
Nkarta is laying off a third of its employees, including half of the executive leadership, as the company channels cash to its lead CAR NK candidate
- Nkarta (NKTX) Stock Price Overview
A detailed overview of Nkarta, Inc (NKTX) stock, including real-time price, chart, key statistics, news, and more
- Nkarta Inc (NKTX) Stock Price News - Google Finance
Get the latest Nkarta Inc (NKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
- Nkarta Inc. Stock Quote (U. S. : Nasdaq) - MarketWatch
Nkarta, Inc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer
- Nkarta, Inc. - LinkedIn
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies
- About Nkarta Disease-Modifying Therapies | Nkarta, Inc.
Nkarta’s lead investigational program is NKX019, a CAR NK cell therapy targeting the CD19 antigen It is designed to be a safe, disease-modifying and accessible treatment with the potential to transform the standard of care for B cell-mediated autoimmune diseases
- NKTX Stock Price Quote | Morningstar
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies
- Nkarta Inc. Financials | NKTX | Barrons
Nkarta, Inc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer
|
|